menu
    • menu
    [{"orgOrder":0,"company":"Liaoning Chengda Biotechnology Co., Ltd","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2024","type":"Inapplicable","leadProduct":"Inactivated Japanese Encephalitis Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Liaoning Chengda Biotechnology Co., Ltd","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Liaoning Chengda Biotechnology Co., Ltd \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Liaoning Chengda Biotechnology Co., Ltd \/ Undisclosed"},{"orgOrder":0,"company":"Liaoning Chengda Biotechnology Co., Ltd","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2024","type":"Inapplicable","leadProduct":"Inactivated Japanese Encephalitis Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Liaoning Chengda Biotechnology Co., Ltd","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Liaoning Chengda Biotechnology Co., Ltd \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Liaoning Chengda Biotechnology Co., Ltd \/ Undisclosed"},{"orgOrder":0,"company":"Liaoning Chengda Biotechnology Co., Ltd","sponsor":"Zhejiang Provincial CDC","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2025","type":"Inapplicable","leadProduct":"Inactivated Japanese Encephalitis Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Liaoning Chengda Biotechnology Co., Ltd","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"Liaoning Chengda Biotechnology Co., Ltd \/ Zhejiang Provincial CDC","highestDevelopmentStatusID":"11","companyTruncated":"Liaoning Chengda Biotechnology Co., Ltd \/ Zhejiang Provincial CDC"},{"orgOrder":0,"company":"Liaoning Chengda Biotechnology Co., Ltd","sponsor":"Liaoning Chengda Biotechnology Co., Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2021","type":"Inapplicable","leadProduct":"Japanese Encephalitis Vaccine, Inactivated","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"Liaoning Chengda Biotechnology Co., Ltd","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Liaoning Chengda Biotechnology Co., Ltd \/ Liaoning Chengda Biotechnology Co., Ltd","highestDevelopmentStatusID":"11","companyTruncated":"Liaoning Chengda Biotechnology Co., Ltd \/ Liaoning Chengda Biotechnology Co., Ltd"}]

    Find Clinical Drug Pipeline Developments & Deals by Liaoning Chengda Biotechnology Co., Ltd

    Menu

    Liaoning Chengda Biotechnology Co., Ltd

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Liaoning Chengda Biotechnology Co., Ltd

                            China arrow
                            Florida Innovation
                            Not Confirmed

                            Liaoning Chengda Biotechnology Co., Ltd

                            China arrow
                            Florida Innovation
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inactivated Japanese Encephalitis Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Sponsor : Zhejiang Provincial CDC

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encepha...

                            Details : Inactivated Japanese Encephalitis Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Japanese Encephalitis Vaccines.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            February 13, 2025

                            Lead Product(s) : Inactivated Japanese Encephalitis Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Sponsor : Zhejiang Provincial CDC

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Liaoning Chengda Biotechnology Co., Ltd

                            China arrow
                            Florida Innovation
                            Not Confirmed

                            Liaoning Chengda Biotechnology Co., Ltd

                            China arrow
                            Florida Innovation
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inactivated Japanese Encephalitis Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas

                            Details : Inactivated Japanese Encephalitis Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Encephalitis, Japanese.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            November 07, 2024

                            Lead Product(s) : Inactivated Japanese Encephalitis Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Liaoning Chengda Biotechnology Co., Ltd

                            China arrow
                            Florida Innovation
                            Not Confirmed

                            Liaoning Chengda Biotechnology Co., Ltd

                            China arrow
                            Florida Innovation
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Inactivated Japanese Encephalitis Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Immunogenicity of Japanese Encephalitis Vaccine Co-administered with Measles-Mumps-Rubella Vaccine (MMR)

                            Details : Inactivated Japanese Encephalitis Vaccine is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Encephalitis, Japanese.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            March 26, 2024

                            Lead Product(s) : Inactivated Japanese Encephalitis Vaccine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Liaoning Chengda Biotechnology Co., Ltd

                            China arrow
                            Florida Innovation
                            Not Confirmed

                            Liaoning Chengda Biotechnology Co., Ltd

                            China arrow
                            Florida Innovation
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Japanese Encephalitis Vaccine, Inactivated

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Recipient : Zhejiang Provincial CDC

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With ...

                            Details : Japanese Encephalitis Vaccine, Inactivated is a Vaccine drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Encephalitis, Japanese.

                            Product Name : Undisclosed

                            Product Type : Vaccine

                            Upfront Cash : Inapplicable

                            March 26, 2021

                            Lead Product(s) : Japanese Encephalitis Vaccine, Inactivated

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Recipient : Zhejiang Provincial CDC

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth